等待开盘 06-18 09:30:00 美东时间
0.000
0.00%
FACTBOX-Major deals involving US drugmakers and biotechs over the past decade Adds GSK deal June 9 (Reuters) - GSK GSK.L has agreed to buy cancer drug developer Nuvalent NUVL.O for $10.6 billion in its biggest deal in years, as the British drugmaker looks to bolster its pipeline and support long-ter
06-09 17:13
July 9 (Reuters) - Merck MRK.N is acquiring UK-based Verona Pharma VRNA.O for about $10 billion, as part of the U.S. drugmaker's strategy to diversify beyond its blockbuster cancer treatment Keytruda....
2025-07-10 01:28
New respiratory treatment could add $3-4 billion in peak sales Merck still looking for acquisitions, could exceed $15 billion Merck shares closed higher Adds closing price in paragraph 7, FACTBOX in r...
2025-07-09 13:36
欧洲生物技术公司Argenx计划在今年夏天发布关键的药物试验数据。该公司正受到大型制药公司密切关注。
2023-05-17 21:42
For many, the main point of investing in the stock market is to achieve spectac...
2023-05-17 18:35
Jefferies analyst Michael Yee downgrades Prometheus Biosciences (NASDAQ:RXDX) from Buy to Hold and raises the price target from $160 to $200.
2023-05-10 17:56
NEW YORK, May 1, 2023 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or b...
2023-05-02 05:22